Agios Pharmaceuticals | AGIO - 市值



金融业
股票价格
USD 31.38
资产
USD 1.06B
现金及等价物
USD 128.55M
销售成本
USD 3M
流动资产
USD 752.1M
流动负债
USD 77.59M
债务
USD 31.17M
EBIT
USD -110.55M
EBITDA
USD -109.2M
员工
486
EPS每股收益
USD -1.09
股本和储备
USD 979.34M
销售毛利
USD 52.86M
债务利息支出
USD 1.06B
利息收入
USD 9.73M
贷款资金
USD 1.06M
市值
USD 1.68B
净收入
USD -100.7M
营业费用
USD 155.3M
营业利润
USD -110.55M
普通股股本
USD 59.61M
PE价格收益
3.56
税前利润
USD -65.05M
销售收入
USD 55.38M
销售和管理费用
USD 51.55M
股票
USD 37.84M
贸易债权人
USD 19.93M
应收帐款人
USD 24.22M


市值 更改 日
AbbVie USD 508.97B 46.71B 2026-11
Agios Pharmaceuticals USD 1.61B 598M 2026-11
Alnylam Pharmaceuticals USD 33.02B 7.17B 2026-09
Amgen USD 247.94B 20.06B 2026-11
Arrowhead Research USD 11.5B 2.72B 2026-06
Astellas Pharma JPY 4.78T 582.95B 2026-11
AstraZeneca USD 213.88B 23.43B 2026-11
Bayer EUR 52.42B 5.31B 2026-11
Biogen USD 33.38B 1.48B 2026-09
BioMarin Pharmaceutical USD 10.68B 936M 2026-11
Bristol-Myers Squibb USD 127.46B 9.81B 2026-09
Daiichi Sankyo JPY 5.22T 356.74B 2026-09
Eli Lilly USD 1.09T 40.33B 2026-09
Exelixis USD 19.82B 5.34B 2026-11
Gilead Sciences USD 184.82B 27.96B 2026-09
GlaxoSmithKline GBP 74.11B 6.03B 2026-09
Incyte USD 24.6B 1.95B 2026-09
Ionis Pharmaceuticals USD 4.52B 2.9B 2026-11
Merck USD 375.59B 17.09B 2026-11
Moderna USD 99.14B 22.26B 2026-11
Nektar Therapeutics USD 2.12B 1.26B 2026-03
Novartis USD 292.09B 51.5B 2026-09
Novartis USD 328.21B 54.92B 2026-11
Pfizer USD 165.12B 1.71B 2026-11
Roche Holding CHF 270B 3.66B 2026-06
Sarepta Therapeutics USD 1.65B 276M 2026-11
Vertex Pharmaceuticals USD 140.44B 7.93B 2026-11